DCT

1:25-cv-13865

Board Of Regents Of University Of Texas System v. Alnylam Pharma Inc

General
Filed
12/16/25
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
--
Plaintiff
Defendant
Party